Your browser doesn't support javascript.
loading
Phosphorylated proteomics analysis of human coronary artery endothelial cells stimulated by Kawasaki disease patients serum.
Li, Shui-Ming; Liu, Wan-Ting; Yang, Fang; Yi, Qi-Jian; Zhang, Shuai; Jia, Hong-Ling.
Afiliação
  • Li SM; College of Life Sciences and Oceanography, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen, Guangdong, China.
  • Liu WT; Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China.
  • Yang F; Department of Pediatrics, First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Yi QJ; Department of Cardiovascular Medicine, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child development and Disorder, China International Science and Technology Coorperation base of Child development and Critical Disorder, Chongqing Key Laboratory of Ped
  • Zhang S; Department of Medical Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jinan University, Guangzhou, Guangdong, China. plum808@yeah.net.
  • Jia HL; Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China. jiahongling@aliyun.com.
BMC Cardiovasc Disord ; 19(1): 21, 2019 01 17.
Article em En | MEDLINE | ID: mdl-30654760
BACKGROUND: Kawasaki disease (KD) is an acute febrile childhood systemic vasculitis that disturbs coronary arteries. The pathogenesis remains unknown. The study of phosphorylated proteins helps to elucidate the relevant pathophysiological mechanisms of cardiovascular disease. However, few researches explored phosphorylated proteins in KD patients. METHODS: We compared phosphoprotein profiles of HCAECs stimulated by the serum of KD patients and normal children using iTRAQ technology, TiO2 enrichment phosphorylated peptide and MS analysis. Then we conducted the functional analysis by ClueGO and the biological interaction networking analysis by ReactomeFIViz. Western blotting was performed to identify the hub proteins. RESULTS: Our results revealed that phosphorylation of 148 proteins showed different intensities between the two HCAECs groups, which are enriched in MAPK, VEGFR, EGFR, Angiopoietin receptor, mTOR, FAK signaling pathway and so on. Through the Network Analyzer analysis, the hub proteins are CDKN1A, MAPK1 and POLR2A, which were experimentally validated. CONCLUSION: In summary, we provided evidence addressing the valuable phosphorylation signaling that could be useful resource to understand the molecular mechanism and the potential targets for novel therapy of KD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Vasos Coronários / Proteômica / Células Endoteliais / Síndrome de Linfonodos Mucocutâneos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Vasos Coronários / Proteômica / Células Endoteliais / Síndrome de Linfonodos Mucocutâneos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article